From 2013 to 2023, the per capita market size value for Penicillins and Streptomycins in El Salvador increased from $2.84 to $4.03. Over the last two years, the market showed a moderate growth of 1.77% in 2023, following a brief decline of 7.48% in 2022. The five-year compound annual growth rate (CAGR) from 2018 to 2023 was approximately 2.12%, indicating steady growth in this timeframe.
Future trends to watch for:
- Continued growth is anticipated due to increased healthcare access and antibiotic use.
- Potential market fluctuations may arise from regulatory changes and drug resistance challenges.
- Innovation and new product launches could further drive market dynamics.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 11 | 11 Luxembourg | 5.24 | 2023 | View data | ||
| 12 | 12 Portugal | 4.91 | 2023 | View data | ||
| 13 | 13 El Salvador | 4.03 | 2023 | |||
| 14 | 14 Spain | 3.89 | 2023 | View data | ||
| 15 | 15 Poland | 3.78 | 2023 | View data | ||
